The Quality Incentive Program.
The end-stage renal disease (ESRD) Quality Incentive Program (QIP) is the first Medicare program that links provider or facility payments to performance, based on outcomes assessed through specific quality measures. These measures are important indicators of patient outcomes and are at the core of medical management of ESRD patients.
What is the Quality Incentive Program (QIP)?
The ESRD QIP is the nation's first pay-for-performance (also known as "value-based purchasing") quality incentive program developed by CMS and mandated by the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) section 153(c). This program provides the ESRD community with the opportunity to enhance the overall quality of care that patients with ESRD receive as they battle this devastating disease.
The ten measures adopted for Payment Year (PY) 2015 of the ESRD QIP include clinical and reporting measures alike. The six clinical measures include the percentage of Medicare patients with an average Hemoglobin >12.0 g/dL, measures of dialysis adequacy (including measures for adult hemodialysis, adult peritoneal dialysis, and pediatric hemodialysis), and measures of vascular access type (including measures for arterial venous fistula and catheter). The four reporting measures address anemia management, dialysis event reporting to the National Healthcare Safety Network (NHSN), In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) patient experience of care survey, and mineral metabolism reporting. These measures are at the core of medical management of patients with ESRD.
FOR DIALYSIS FACILITIES
DialysisReports.org is administered by:
Arbor Research Collaborative for Health and the University of Michigan Kidney Epidemiology and Cost Center (KECC).
For information about the availability of auxiliary aids and services, please visit: